Figure 6
Expression of VEGF protein. Shown is the immunostaining of VEGF in the CNV lesions on Day 28 in eyes from the Control (A), CNV (B), CNV with bevacizumab (C), and CNV with HB01 (D) groups. The relative expression of VEGF protein was summarized in (E). *P < 0.01, Mann Whitney test; NS, not significant. Arrows marked CNV lesions.